CC
LFCR icon

Corton Capital’s Lifecore Biomedical LFCR Stock Holding History

Corton Capital’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$88.6K Buy
+12,043
New +$91.1K 0.22% 181
2024
Q3 		– Sell
-12,118
Closed -$62.2K – 584
2024
Q2 		$62.2K Buy
+12,118
New +$71.8K 0.03% 465

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corton Capital's LFCR Position: Q3 2025 in Review

Corton Capital opened a new position in Lifecore Biomedical (LFCR) in Q3 2025: 12,043 shares worth $88.6K. The stake represents 0.22% of the portfolio and ranks #181 among its holdings. This is a return to the name: Corton Capital previously reported a position in LFCR as recently as Q2 2024.

Corton Capital first reported a position in LFCR in Q2 2024 and has held it in 2 quarters since. 100 funds tracked by Wall St. Rank hold LFCR as of Q3 2025.

  • Corton Capital held 12,043 shares of Lifecore Biomedical worth $88.6K as of Q3 2025.
  • Lifecore Biomedical was a new Corton Capital position in Q3 2025.
  • Lifecore Biomedical made up 0.22% of Corton Capital's portfolio in Q3 2025, its #181 holding.
  • Corton Capital first reported a position in Lifecore Biomedical in Q2 2024 and has held it in 2 quarters since.
  • 100 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.